Webinar
Using AI at AstraZeneca: from clinical trial design to regulatory
calendar

November 28, 2023

Calendar
clock

11:00am - 12:00pm

(GMT-05:00)

Register

View all IQVIA events

In the fast-paced environment of drug development, pharmaceutical companies need to mine internal and external information quickly and accurately. Many organizations are looking for innovations with NLP (Natural Language Processing), such as large language models, to accelerate drug development. In this webinar, we will discuss how AI (Artificial Intelligence) and NLP are being used at AstraZeneca to facilitate clinical trial design, diversity plans, and health authority advice within regulatory affairs. 

Register now to learn about:

  • What is NLP
  • NLP for efficacy endpoints and clinical trial design
  • NLP to accelerate diversity plans preparation
  • NLP implementation into digital platform to mine health authority advice
Speakers:

Emilie Louvet
Director Regulatory Data Products at AstraZeneca

Constantinos Katevatis
Associate Director, R&D NLP at IQVIA

Related solutions

Contact Us